Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: A 6 Week, Multicenter, Randomized, Double -Blind, Placebo-Controlled Study.

Trial Profile

Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: A 6 Week, Multicenter, Randomized, Double -Blind, Placebo-Controlled Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Nov 2010

At a glance

  • Drugs Eplivanserin (Primary)
  • Indications Insomnia
  • Focus Registrational; Therapeutic Use
  • Acronyms EPOCH
  • Sponsors Sanofi
  • Most Recent Events

    • 16 Jun 2009 Actual initiation date (August 2007), actual patient number (608) added as reported by ClinicalTrials.gov.
    • 26 Nov 2007 Status change from in progress to completed
    • 15 Nov 2007 Eplivanserin is expected to be launched in 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top